ValiRx Statistics

Total Valuation

ValiRx has a market cap or net worth of EUR 2.53 million. The enterprise value is 1.45 million.

Market Cap	2.53M
Enterprise Value	1.45M

Important Dates

The next estimated earnings date is Tuesday, May 26, 2026.

Earnings Date	May 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	742.72M
Shares Outstanding	n/a
Shares Change (YoY)	+116.98%
Shares Change (QoQ)	+182.84%
Owned by Insiders (%)	11.17%
Owned by Institutions (%)	35.90%
Float	658.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	43.65
PB Ratio	0.72
P/TBV Ratio	1.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.70
EV / Sales	25.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.74

Financial Position

The company has a current ratio of 9.66, with a Debt / Equity ratio of 0.00.

Current Ratio	9.66
Quick Ratio	8.87
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-638.72

Financial Efficiency

Return on equity (ROE) is -57.69% and return on invested capital (ROIC) is -38.56%.

Return on Equity (ROE)	-57.69%
Return on Assets (ROA)	-37.13%
Return on Invested Capital (ROIC)	-38.56%
Return on Capital Employed (ROCE)	-66.99%
Revenue Per Employee	4,148
Profits Per Employee	-148,593
Employee Count	14
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-151,549
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-96.77%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	8.99
Average Volume (20 Days)	5,500

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ValiRx had revenue of EUR 58,067 and -2.08 million in losses. Loss per share was -0.01.

Revenue	58,067
Gross Profit	58,067
Operating Income	-2.35M
Pretax Income	-2.34M
Net Income	-2.08M
EBITDA	-2.06M
EBIT	-2.35M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 605,224 in cash and 7,771 in debt, giving a net cash position of 597,453.

Cash & Cash Equivalents	605,224
Total Debt	7,771
Net Cash	597,453
Net Cash Per Share	n/a
Equity (Book Value)	3.51M
Book Value Per Share	0.01
Working Capital	883,271

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.94 million and capital expenditures -24,775, giving a free cash flow of -1.97 million.

Operating Cash Flow	-1.94M
Capital Expenditures	-24,775
Free Cash Flow	-1.97M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-4,053.38%
Pretax Margin	-4,037.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ValiRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-116.98%
Shareholder Yield	-116.98%
Earnings Yield	-82.07%
FCF Yield	-77.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 6, 2020. It was a reverse split with a ratio of 0.008.

Last Split Date	Apr 6, 2020
Split Type	Reverse
Split Ratio	0.008

Scores

ValiRx has an Altman Z-Score of -3.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.41
Piotroski F-Score	3